RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 90.7%

Neg 90.7% Neu 0% Pos 0%

RBC Capital analyst Leonid Timashev downgrades Biohaven (NYSE:BHVN) from Outperform to Sector Perform and lowers the price target from $23 to $19.